First-in-human Phase 1 study in 56 healthy participants demonstrated KIT2014’s safety and tolerability KIT2014 is being developed as an inhalation therapy for respiratory diseases including chronic ...

Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.

Medable Inc., the leading technology platform for agentic clinical development, today announced its Digital Data Flow (DDF) Agent, which automatically transforms static clinical trial protocols into ...

Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for ...

Developed in collaboration with Korea's top clinical and hospital network, the integrated platform combines globally ...

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that ...

RECIST v1.1 in patients with platinum-resistant ovarian cancer (“PROC”) who progressed on a median of 7 prior lines of therapy Cytokine Release Syndrome (“CRS”) in PROC limited to Grade 1 in 11% of ...

AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...

PM577a targets the H1069Q mutation in the ATP7B gene, the most prevalent WD-causing allele in North America and Europe -- -- Initiation of Phase 1/2 clinical trial expected in second half of 2026; ...

In countries with the best cancer outcomes, approximately 60% of patients receive radiotherapy as part of their treatment, which is one of the most cost-effective cancer treatments. Notably, around 40 ...

This appendix, which is a collection of clinical practice guidelines and related materials, 2 has three main purposes. First, for readers not familiar with guidelines, it presents samples that may ...